JPM

JPMorgan is the highest-quality money-center bank in the US and the numbers show a franchise at peak strength: revenue of $182B (+2.8%), a 31.3% net margin, and a 15.7% ROE that is healthy for a bank of this scale. Retained earnings grew 10.6% to $416B and equity rose 5.1% to $362B, while the firm returned cash hand over fist — $31.6B in buybacks (+67.8% YoY) and $16.6B in dividends (+12.5%) — shrinking the share count 3.5%. That capital return is what lifted diluted EPS to $20.02 (+1.4%) even as net income actually fell 2.4% to $57.0B. The 10-K's own controls and disclosures are clean (PwC sign-off, no material weaknesses, effective disclosure controls), and insider 10b5-1 plans are routine PSU-vesting sales, not red flags.

The catch is that the earnings engine has flattened at a very high altitude. Net income peaked at $58.5B in FY2024 and slipped to $57.0B in FY2025; the four-year run from $122B to $182B of revenue is decelerating to low-single-digit growth. So the EPS line is increasingly a buyback story rather than an organic-earnings story — a fine outcome for holders, but not the profile of a compounding grower. The 10-K's risk summary leans heavily on market risk (interest rates and credit spreads), credit risk (deterioration in client financial condition and collateral values), and political/economic uncertainty — exactly the macro-sensitive exposures that determine whether a bank at the top of the cycle can hold these earnings, and which give little margin for upside surprise from here.